| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 51, 520-528, Copyright © 1980 by Endocrine Society
ARTICLES |
RP Eaton, RC Allen, DS Schade, KM Erickson and J Standefer
The prehepatic production of insulin in normal man was evaluated by kinetic analysis of connecting peptide (C-peptide) behavior in the plasma in men and women. Studies were performed during suppression of endogenous insulin secretion (induced by both fasting and exogenous insulin injection) as well as during stimulation of secretion (induced by oral glucose ingestion) and iv glucose injection. Least squares spline fitting of the C-peptide data by interactive computer analysis permitted evaluation of the precursor production of insulin using a two- compartment model for C-peptide removal. Basal prehepatic insulin production averaged 15-4 mU/70 kg.min in 20 subjects and was reduced to 0.9 +/- 2.2 mU/70 kg.min after 84 h of fasting. The injection of exogenous iv insulin resulted in suppression of endogenous production to 0 +/- 2.5 mU/70 kg.min. Maximum prehepatic insulin production induced by a 100-g oral glucose tolerance test was 91 +/- 1.2 mU/70 kg.min, with a cumulative hormone secretion of 11.4 +/- 2.0 U over the 5 h of observation. After the acute iv injection of 25 g glucose, production rose to 465 +/- 108 mU/70 kg.min at 2 min post injection and rapidly returned toward basal. Levels of insulin in the portal vein calculated from this analysis were markedly elevated relative to simultaneous peripheral venous levels. These results quantitate prehepatic insulin production and portal venous insulin concentration from an analysis of the behavior of C-peptide within the plasma in both the steady state and the nonsteady state in man.
This article has been cited by other articles:
![]() |
L. Perreault, B. C. Bergman, M. C. Playdon, C. Dalla Man, C. Cobelli, and R. H. Eckel Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E428 - E435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Erdmann, B. Kallabis, U. Oppel, O. Sypchenko, S. Wagenpfeil, and V. Schusdziarra Development of hyperinsulinemia and insulin resistance during the early stage of weight gain Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E568 - E575. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cobelli, G. M. Toffolo, C. D. Man, M. Campioni, P. Denti, A. Caumo, P. Butler, and R. Rizza Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E1 - E15. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bertuzzi, S. Salinari, and G. Mingrone Insulin granule trafficking in beta-cells: mathematical model of glucose-induced insulin secretion Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E396 - E409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Campioni, G. Toffolo, L. T. Shuster, F. J. Service, R. A. Rizza, and C. Cobelli Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E54 - E60. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Toffolo, M. Campioni, R. Basu, R. A. Rizza, and C. Cobelli A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E169 - E176. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fehse, M. Trautmann, J. J. Holst, A. E. Halseth, N. Nanayakkara, L. L. Nielsen, M. S. Fineman, D. D. Kim, and M. A. Nauck Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5991 - 5997. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Camastra, M. Manco, A. Mari, S. Baldi, A. Gastaldelli, A. V. Greco, G. Mingrone, and E. Ferrannini {beta}-Cell Function in Morbidly Obese Subjects During Free Living: Long-Term Effects of Weight Loss Diabetes, August 1, 2005; 54(8): 2382 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Gosmanov, E. Szoke, Z. Israelian, T. Smith, P. E. Cryer, J. E. Gerich, and C. Meyer Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans Diabetes Care, May 1, 2005; 28(5): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ferrannini, S. Camastra, A. Gastaldelli, A. Maria Sironi, A. Natali, E. Muscelli, G. Mingrone, and A. Mari Beta-Cell Function in Obesity: Effects of Weight Loss Diabetes, December 1, 2004; 53(suppl_3): S26 - S33. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nauck, B. Baller, and J. J. Meier Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in the Pathogenesis of Type 2 Diabetes Diabetes, December 1, 2004; 53(suppl_3): S190 - S196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caumo and L. Luzi First-phase insulin secretion: does it exist in real life? Considerations on shape and function Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Rudovich, H. J. Rochlitz, and A. F.H. Pfeiffer Reduced Hepatic Insulin Extraction in Response to Gastric Inhibitory Polypeptide Compensates for Reduced Insulin Secretion in Normal-Weight and Normal Glucose Tolerant First-Degree Relatives of Type 2 Diabetic Patients Diabetes, September 1, 2004; 53(9): 2359 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Steil, C.-m. Hwu, R. Janowski, F. Hariri, S. Jinagouda, C. Darwin, S. Tadros, K. Rebrin, and M. F. Saad Evaluation of Insulin Sensitivity and {beta}-Cell Function Indexes Obtained From Minimal Model Analysis of a Meal Tolerance Test Diabetes, May 1, 2004; 53(5): 1201 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Steele, W. A. Hagopian, S. Gitelman, U. Masharani, M. Cavaghan, K. I. Rother, D. Donaldson, D. M. Harlan, J. Bluestone, and K. C. Herold Insulin Secretion in Type 1 Diabetes Diabetes, February 1, 2004; 53(2): 426 - 433. [Abstract] [Full Text] |
||||
![]() |
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al. C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001 Diabetes, January 1, 2004; 53(1): 250 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen and T. O. Scholl Ethnic Differences in C-Peptide/Insulin/Glucose Dynamics in Young Pregnant Women J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4642 - 4646. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tschritter, M. Stumvoll, F. Machicao, M. Holzwarth, M. Weisser, E. Maerker, A. Teigeler, H. Haring, and A. Fritsche The Prevalent Glu23Lys Polymorphism in the Potassium Inward Rectifier 6.2 (KIR6.2) Gene Is Associated With Impaired Glucagon Suppression in Response to Hyperglycemia Diabetes, September 1, 2002; 51(9): 2854 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banarer, V. P. McGregor, and P. E. Cryer Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response Diabetes, April 1, 2002; 51(4): 958 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nauck, M. M. Heimesaat, K. Behle, J. J. Holst, M. S. Nauck, R. Ritzel, M. Hufner, and W. H. Schmiegel Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Juhl, M. Hollingdal, J. Sturis, G. Jakobsen, H. Agerso, J. Veldhuis, N. Porksen, and O. Schmitz Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes Diabetes, February 1, 2002; 51(2): 424 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mari, A. Tura, A. Gastaldelli, and E. Ferrannini Assessing Insulin Secretion by Modeling in Multiple-Meal Tests: Role of Potentiation Diabetes, February 1, 2002; 51(90001): S221 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Breda, G. Toffolo, K. S. Polonsky, and C. Cobelli Insulin Release in Impaired Glucose Tolerance: Oral Minimal Model Predicts Normal Sensitivity to Glucose but Defective Response Times Diabetes, February 1, 2002; 51(90001): S227 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fritsche, A. Madaus, N. Stefan, O. Tschritter, E. Maerker, A. Teigeler, H. Haring, and M. Stumvoll Relationships Among Age, Proinsulin Conversion, and {beta}-Cell Function in Nondiabetic Humans Diabetes, February 1, 2002; 51(90001): S234 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Simon and G. Brandenberger Ultradian Oscillations of Insulin Secretion in Humans Diabetes, February 1, 2002; 51(90001): S258 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fritsche, A. Madaus, W. Renn, O. Tschritter, A. Teigeler, M. Weisser, E. Maerker, F. Machicao, H. Haring, and M. Stumvoll The Prevalent Gly1057Asp Polymorphism in the Insulin Receptor Substrate-2 Gene Is Not Associated with Impaired Insulin Secretion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4822 - 4825. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Magnan, C. Cruciani, L. Clement, P. Adnot, M. Vincent, M. Kergoat, A. Girard, J.-L. Elghozi, G. Velho, N. Beressi, et al. Glucose-Induced Insulin Hypersecretion in Lipid-Infused Healthy Subjects Is Associated with a Decrease in Plasma Norepinephrine Concentration and Urinary Excretion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4901 - 4907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stumvoll, A. Fritsche, A. Madaus, N. Stefan, M. Weisser, F. Machicao, and H. Haring Functional Significance of the UCSNP-43 Polymorphism in the CAPN10 Gene for Proinsulin Processing and Insulin Secretion in Nondiabetic Germans Diabetes, September 1, 2001; 50(9): 2161 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brandt, M. Katschinski, R. Arnold, K. S. Polonsky, B. Goke, and M. M. Byrne GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E242 - E247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Gautier, C. Wilson, C. Weyer, D. Mott, W. C. Knowler, M. Cavaghan, K. S. Polonsky, C. Bogardus, and R. E. Pratley Low Acute Insulin Secretory Responses in Adult Offspring of People With Early Onset Type 2 Diabetes Diabetes, August 1, 2001; 50(8): 1828 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Steil, N. Trivedi, J.-C. Jonas, W. M. Hasenkamp, A. Sharma, S. Bonner-Weir, and G. C. Weir Adaptation of {beta}-cell mass to substrate oversupply: enhanced function with normal gene expression Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E788 - E796. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boden, X. Chen, E. Capulong, and M. Mozzoli Effects of Free Fatty Acids on Gluconeogenesis and Autoregulation of Glucose Production in Type 2 Diabetes Diabetes, April 1, 2001; 50(4): 810 - 816. [Abstract] [Full Text] |
||||
![]() |
C. Homko, E. Sivan, X. Chen, E. A. Reece, and G. Boden Insulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 568 - 573. [Abstract] [Full Text] |
||||
![]() |
G. Toffolo, E. Breda, M. K. Cavaghan, D. A. Ehrmann, K. S. Polonsky, and C. Cobelli Quantitative indexes of {beta}-cell function during graded up&down glucose infusion from C-peptide minimal models Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E2 - E10. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boden, X. Chen, and T. P. Stein Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E23 - E30. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Breda, M. K. Cavaghan, G. Toffolo, K. S. Polonsky, and C. Cobelli Oral Glucose Tolerance Test Minimal Model Indexes of {beta}-Cell Function and Insulin Sensitivity Diabetes, January 1, 2001; 50(1): 150 - 158. [Abstract] [Full Text] |
||||
![]() |
T. Laedtke, L. Kjems, N. Porksen, O. Schmitz, J. Veldhuis, P. C. Kao, and P. C. Butler Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E520 - E528. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Simon, L. Weibel, and G. Brandenberger Twenty-four-hour rhythms of plasma glucose and insulin secretion rate in regular night workers Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E413 - E420. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Christiansen, L. L. Kjems, A. Volund, A. Tibell, C. Binder, and S. Madsbad Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E716 - E725. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rostami-Hodjegan, S. R. Peacey, E. George, S. R. Heller, and G. T. Tucker Population-based modeling to demonstrate extrapancreatic effects of tolbutamide Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E758 - E771. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hovorka, L. Chassin, S. D. Luzio, R. Playle, and D. R. Owens Pancreatic {beta}-Cell Responsiveness during Meal Tolerance Test: Model Assessment in Normal Subjects and Subjects with Newly Diagnosed Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 744 - 750. [Abstract] [Full Text] |
||||
![]() |
R. M. Watanabe, G. M. Steil, and R. N. Bergman Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E172 - E183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nauck, U. Niedereichholz, R. Ettler, J. J. Holst, C. Orskov, R. Ritzel, and W. H. Schmiegel Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E981 - E988. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Ehrmann, D. J. Schneider, B. E. Sobel, M. K. Cavaghan, J. Imperial, R. L. Rosenfield, and K. S. Polonsky Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2108 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Peacey, A. Rostami-Hodjegan, E. George, G. T. Tucker, and S. R. Heller The Use of Tolbutamide-Induced Hypoglycemia to Examine the Intraislet Role of Insulin in Mediating Glucagon Release in Normal Humans J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1458 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Ehrmann, M. K. Cavaghan, J. Imperial, J. Sturis, R. L. Rosenfield, and K. S. Polonsky Effects of Metformin on Insulin Secretion, Insulin Action, and Ovarian Steroidogenesis in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 524 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kato, T. Takashima, K. Ohmori, and T. Sunaga Urine C-Peptide and Atherogenic Risk Factors in Diabetes Mellitus: Relevance to "Syndrome X" Angiology, October 1, 1995; 46(10): 915 - 921. [Abstract] [PDF] |
||||
![]() |
J. Meyer, J. Sturis, M. Katschinski, R. Arnold, B. Goke, and M. M. Byrne Acute hyperglycemia alters the ability of the normal beta -cell to sense and respond to glucose Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E917 - E922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |